Acute toxicity of hypofractionated IMRT with simultaneous integrated boost in high-risk prostate cancer patients

被引:0
|
作者
Lecavalier-Barsoum, M. [1 ]
Faria, S. [1 ]
Ruo, R. [1 ]
Cury, F. [1 ]
David, M. [1 ]
Duclos, M. [1 ]
Souhami, L. [1 ]
机构
[1] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2879
引用
收藏
页码:S689 / S689
页数:1
相关论文
共 50 条
  • [1] Hypofractionated IMRT With Simultaneous Integrated Boost for High-risk Prostate Cancer Patients: Acute Toxicity Report
    Lecavalier-Barsoum, M.
    Faria, S.
    Ruo, R.
    Cury, F.
    David, M.
    Duclos, M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S364 - S364
  • [2] PELVIC IMRT AND HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO HIGH-RISK PROSTATE CANCER
    Alessandro, Magli
    De Giorgi, Gioacchino
    Ceschia, Tino
    Crivellaro, Simone
    Marino, Marco
    Parisi, Giuseppe
    Signor, Marco
    Titone, Francesca
    Frea, Bruno
    Fongione, Sandro
    [J]. ANTICANCER RESEARCH, 2011, 31 (05) : 1876 - 1877
  • [3] IMRT simultaneous integrated boost for high-risk prostate cancer
    Li, X
    Wang, JZ
    Jursinic, P
    Lawton, CA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S632 - S633
  • [4] Hypofractionated Simultaneous Integrated Boost IMRT in high risk prostate cancer - A novel approach
    Sashidharan, S.
    Beena, K.
    Chelakkot, P. G.
    Madhavan, R.
    Menon, D.
    Makuny, D.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S636 - S636
  • [5] PELVIC IMRT WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST TO HIGH RISK (SCORE NCCN) PROSTATE CANCER
    Magli, A.
    Malisan, M. R.
    Foti, C.
    Moretti, E.
    Marino, M.
    Prisco, A.
    Polsinelli, M.
    Signor, M.
    Fongione, S.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S411 - S411
  • [6] Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer
    Li, XA
    Wang, JZ
    Jursinic, PA
    Lawton, CA
    Wang, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (04): : 1251 - 1257
  • [7] ACUTE AND LATE TOXICITY OF PELVIC RADIOTHERAPY AND CONCOMITANT HYPOFRACTIONATED IMRT BOOST COMBINED WITH HORMONAL THERAPY FOR HIGH-RISK PROSTATE CANCER
    Quon, H.
    Loblaw, A.
    Morton, G.
    Sixel, K.
    Pang, G.
    Basran, P.
    Szumacher, E.
    Danjoux, C.
    Choo, R.
    Thomas, G.
    Kiss, A.
    Deabreu, A.
    Cheung, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S47 - S47
  • [8] WHOLE-PELVIC NODAL IRRADIATION WITH HYPOFRACTIONATED SIMULTANEOUS INTEGRATED BOOST FOR HIGH-RISK PROSTATE CANCER: OUTCOME AND LATE TOXICITY
    Magli, Alessandro
    Moretti, Eugenia
    Tullio, Annarita
    Ceschia, Tino
    Chiaulon, Germana
    Parisi, Giuseppe
    Signor, Marco Andrea
    Crespi, Margherita
    Foti, Claudio
    De Giorgi, Gioacchino
    Sacco, Cosimo Stanislao
    [J]. ANTICANCER RESEARCH, 2017, 37 (04) : 2070 - 2071
  • [9] Concomitant Hypofractionated IMRT Boost for High-Risk Prostate Cancer: 5 Year Results
    Cheung, P.
    Loblaw, D.
    Szumacher, E.
    Danjoux, C.
    Choo, R.
    Zhang, L.
    Mamedov, A.
    Deabreu, A.
    Morton, G.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S106 - S106
  • [10] Risk factors for acute toxicity in prostate cancer patients receiving hypofractionated IMRT
    Matrone, F.
    Montesi, G.
    Saldi, S.
    Bellavita, R.
    Frattegiani, A.
    Lupattelli, M.
    Zucchetti, C.
    Cusco, S.
    Bini, V.
    Aristei, C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S680 - S681